Lynn A. Tetrault - 18 May 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
Director
Signature
/s/ Ali Olivo, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
18 May 2022
Net transactions value
+$24,238
Form type
4
Filing time
20 May 2022, 17:08:42 UTC
Previous filing
13 Oct 2021
Next filing
10 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Options Exercise $24,238 +3,334 +9.3% $7.27 39,111 18 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Options Exercise $0 -3,334 -100% $0.000000* 0 18 May 2022 Common Stock 3,334 $7.27 Direct F1
holding NEO Stock Option (Right to Buy) 1,507 18 May 2022 Common Stock 1,507 $11.60 Direct
holding NEO Stock Option (Right to Buy) 2,136 18 May 2022 Common Stock 2,136 $22.52 Direct
holding NEO Stock Option (Right to Buy) 3,448 18 May 2022 Common Stock 3,448 $28.54 Direct
holding NEO Stock Option (Right to Buy) 3,714 18 May 2022 Common Stock 3,714 $40.90 Direct
holding NEO Stock Option (Right to Buy) 972 18 May 2022 Common Stock 972 $41.76 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On May 25, 2017, Lynn Tetrault was granted 10,000 stock options. The options vest ratably on the next three anniversary dates of the grant date.